MedTrace Logo

Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus

NCT03804723 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 321

Last updated 2019-01-18

No results posted yet for this study

Summary

This is a 36 months, randomized, double-blind, placebo-controlled, parallel-groups, equivalence multicenter trial in patients with inactive Systemic Lupus Erythematosus to evaluate if low disease activity can be sustained with withdrawal of glucocorticoids in patients on stable clinical remission or low disease activity.

Conditions

Interventions

DRUG

oral Prednisone 5mg

patients randomized to this arm will stop prednisone 5 mg

Sponsors & Collaborators

  • University of Pisa

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-30
Primary Completion
2022-06-30
Completion
2023-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03804723 on ClinicalTrials.gov